Reperfusion therapy in out-of-hospital cardiac arrest: current insights.
Although early care in out-of-hospital cardiac arrest has been improved over the past decades, survival remains poor and neurological performance after survival is often impaired. Consequently, new therapies are needed to improve outcome. As thrombotic processes such as acute myocardial infarction or pulmonary embolism are frequent causes of cardiac arrest, therapies like fibrinolysis or percutaneous coronary intervention are of interest. Both therapies can restore coronary and pulmonary perfusion in cardiac arrest patients and, additionally, fibrinolysis might prevent microthrombi to the brain. In this review, the rationale, safety and efficacy of reperfusion therapy in patients with out-of-hospital cardiac arrest will be discussed.
Keuper
Wessel
W
Radboud University Nijmegen Medical Centre, Department of Cardiology, Geert Grooteplein 10, 6525 GA Nijmegen, The Netherlands. w.keuper@cardio.umcn.nl <w.keuper@cardio.umcn.nl>
Dieker
Hendrik-Jan
HJ
Brouwer
Marc A
MA
Verheugt
Freek W A
FW
D016887:Cardiopulmonary Resuscitation; D004632:Emergency Medical Services; D005343:Fibrinolytic Agents / Q000494:pharmacology*; D006323:Heart Arrest / Q000628:therapy*; D006801:Humans; D016896:Treatment Outcome
D005343:Fibrinolytic Agents